Search Orphan Drug Designations and Approvals
-
Generic Name: | mebendazole |
---|---|
Date Designated: | 11/22/2022 |
Orphan Designation: | Treatment of Autosomal Dominant Polycystic Kidney Disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Healx Technology Limited Charter House, 66-68 Hills Road Cambridge CB2 1LA United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-